HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 92 filers reported holding HARVARD BIOSCIENCE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,201,239 | -21.7% | 279,358 | 0.0% | 0.32% | -0.9% |
| Q2 2023 | $1,533,675 | -73.2% | 279,358 | -79.5% | 0.32% | -75.2% |
| Q1 2023 | $5,719,430 | +51.6% | 1,361,769 | 0.0% | 1.28% | +17.4% |
| Q4 2022 | $3,772,100 | +12.9% | 1,361,769 | +4.3% | 1.10% | +84.3% |
| Q3 2022 | $3,342,000 | -2.9% | 1,305,525 | +36.5% | 0.59% | -24.6% |
| Q2 2022 | $3,443,000 | -19.2% | 956,476 | +39.4% | 0.79% | +49.8% |
| Q1 2022 | $4,262,000 | -11.9% | 686,236 | 0.0% | 0.53% | -17.3% |
| Q4 2021 | $4,838,000 | -5.9% | 686,236 | -6.8% | 0.64% | -12.4% |
| Q3 2021 | $5,139,000 | -17.2% | 736,236 | -1.2% | 0.73% | +3.9% |
| Q2 2021 | $6,206,000 | +28.9% | 745,019 | -15.5% | 0.70% | +1.0% |
| Q1 2021 | $4,815,000 | +27.3% | 881,794 | 0.0% | 0.69% | +6.0% |
| Q4 2020 | $3,783,000 | +42.5% | 881,794 | 0.0% | 0.65% | +22.3% |
| Q3 2020 | $2,654,000 | +4.7% | 881,794 | +7.8% | 0.53% | -2.0% |
| Q2 2020 | $2,536,000 | – | 818,048 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |